Errors in the Use of Turbuhaler and Spiromax Devices Patients With Asthma

Completed

• Conditions: Asthma
• Interventions: Device: TURBUHALER®; Device: SPIROMAX®

• Registration Number: NCT02983994
• Lead Sponsor: Fundación Pública Andaluza Progreso y Salud

Brief Summary

The aim of the study is to evaluate the errors that may occur during inhalation of two devices in patients with asthma, as well as to study whether it relates to the degree of control of patient symptoms and the degree of compliance of medication symptoms. Finally, we also want to study the degree of patient satisfaction with each of the inhalers studied

Detailed Description

Not available

Study Timeline

• Study Start: 2016-11
• Study First Submitted: 2016-11-23
• Study First Submitted QC: 2016-12-02
• Study First Posted: 2016-12-06
• Primary Completion: 2017-05
• Status Verified: 2017-10
• Study Completion: 2017-10-10
• Last Update Submitted: 2018-05-22
• Last Update Posted: 2018-05-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

• Diagnosis of asthma with treatment indication with CI + LABA according to GINA 2015 guide and in dry powder device.
• Over 18 years.
• Patient in stable phase without having had exacerbations in the 3 months previous to the Inclusion in the study

Exclusion Criteria

• Presence of relevant respiratory disease other than asthma (including COPD).
• Refusal to participate in the study and sign informed consent or inability to To give informed consent.
• Patients who have previously been treated with inhaled dust devices dry.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients with asthma with an inhaled steroid	TURBUHALER®	Patients with a diagnosis of asthma with indication of Treatment with an inhaled steroid (CI)
Patients with asthma with an inhaled Beta agonist	SPIROMAX®	Patients with a diagnosis of asthma with indication of Treatment with an inhaled Beta agonist (LABA)

Primary Outcome Measures

Name	Time	Method
The effectiveness of inhaler management.	two months	The effectiveness of inhaler management, It will be the comparison of the means of the number of errors detected between both devices.

Trial Locations

Locations (4)

Hospital Universitario Puerta del Mar; 🇪🇸 Cadiz, Spain

Hospital Universitario Virgen Macarena; 🇪🇸 Sevilla, Spain

Hospital Regional de Málaga; 🇪🇸 Malaga, Spain

Hospital Universitario Virgen del Rocío; 🇪🇸 Sevilla, Spain